References
- Wilkinson TMA, Donaldson GC, Hurst JR, et al. Impact of reporting and rarely therapy on outcome of exacerbations of COPD. Am J Respir Crit Care Med 2004;169:1298-303
- White AJ, Gompertz S, Stockley RA. Review Series. The etiology of chronic obstructive pulmonary disease exacerbations. Thorax 2003;58:73-80
- Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-53
- Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004;364:709-21
- Fahy JV, Dickey BF. Airway mucus function and dysfunction. Editorial. N Engl J Med 2010;363:2233-47
- Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007;29:1224-38
- Vogelmeyer C, Hederer B, Glaab T, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011;364:1093-103
- Thomas M, Decramer M, O’Donnell. No room to breathe: the importance of lung hyperinflation in COPD. Prim Care Respir J 2013;22:101-111
- Feldman GF. Chronic obstructive pulmonary disease research vs. clinical practice: turning point or crossroads. IDDST 2013. 11th Annual Congress of Int’l Drug Discovery Science and Technology, November 2013, Haikou, China (Video Presentation)
- Shimura S. Continuity of airway goblet cells and intraluminal mucus in the airways of patients with bronchial asthma. Eur Respir J 1996;9:1395-401
- Andrews J, Sathe NA, Krishnaswami S, McPheeters ML. Nonpharmacologic airway clearance technique in hospitalized patients: a systematic review. Respir Care 2013;58:2160-86
- Reducing COPD readmissions – a personal and political priority. Lancet Respir Med 2013;1:347